JPRN-UMIN000040909已完成未知
Study of treatment for esophageal cancer - Study of treatment for esophageal cancer
Graduate School of Medical Sciences,Kyushu University0 个研究点目标入组 26 人开始时间: 2020年6月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •thoracotomy, mediastinal endoscopy
研究者
相似试验
进行中（未招募）
1 期
Phase II trial in inoperable œsophageal cancer evaluating the feasibility of the combination of definitive chemoradiation with the immune checkpoint blockers Nivolumab +/- Ipilimumab (CRUCIAL)oesophageal squamous cell carcinoma and oeasophageal adenocarcinomaMedDRA version: 20.0Level: PTClassification code 10061534Term: Oesophageal squamous cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10030137Term: Oesophageal adenocarcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-000053-53-ESEuropean Organisation for Research and Treatment of Cancer130
进行中（未招募）
1 期
Phase II trial in inoperable œsophageal cancer evaluating the feasibility of the combination of definitive chemoradiation with the immune checkpoint blockers Nivolumab +/- Ipilimumab (CRUCIAL)EUCTR2018-000053-53-DEEuropean Organisation for Research and Treatment of Cancer130
已完成
不适用
For advanced or recurrent esophageal cancer Of combination therapy - docetaxel-cisplatin-5 fluorouracil phase I/II trialAdvanced or recurrent esophageal cancerJPRN-UMIN000014625gifu University30
招募中
1 期
Clinical study on the treatment of gastroesophageal reflux cough by the reverse embedding method of tongdu xuanfeiITMCTR2100004898anjing Hospital of Traditional Chinese Medicine
尚未招募
1 期
Juzendaihoto administration for esophageal cancer patientsEsophageal cancerJPRN-UMIN000036616agasaki University35